Home > Balance Sheet > CORONA REMEDIES

CORONA REMEDIES
Total Non-Current Liabilities

    Back to Balance Sheet
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Total Non-Current Liabilities ₹97 Cr₹84 Cr₹126 Cr₹45 Cr

What is the latest Total Non-Current Liabilities ratio of CORONA REMEDIES ?

The latest Total Non-Current Liabilities ratio of CORONA REMEDIES is ₹97 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹97 Cr
Mar2025₹84 Cr
Mar2024₹126 Cr
Mar2023₹45 Cr

How is Total Non-Current Liabilities of CORONA REMEDIES Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹97 Cr
15.70
Mar2025 ₹84 Cr
-33.38
Mar2024 ₹126 Cr
180.69
Mar2023 ₹45 Cr -

Compare Total Non-Current Liabilities of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹13,918.7 Cr 3.5% 12% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹425,150.0 Cr 0.8% -2.1% 4.8% Stock Analytics
DIVIS LABORATORIES ₹266,265.0 Cr 4.9% 7.9% 54.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,300.0 Cr 1.6% -2.7% 28.1% Stock Analytics
DR REDDYS LABORATORIES ₹114,351.0 Cr 2.6% 14.2% 3.9% Stock Analytics
CIPLA ₹112,474.0 Cr 2.4% 3.4% -12% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

3.5%

12%

NA
SENSEX

4.5%

6.1%

-9.3%


You may also like the below Video Courses